surmount-1 tirzepatide trial obesity without diabetes

surmount-1 tirzepatide trial obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 🤔Adults with type 2 diabetes

Name: surmount-1 tirzepatide trial obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 🤔Adults with type 2 diabetes
Brand: aeroscroll.com
SKU: 30227004094
Price: 23.30 USD
Availability: InStock
Rating: 4.7128000000000005 (13 reviews)

SKU: 30227004094

4.7

EUR23.30 EUR71.30

Pay in 4 interest-free payments of $5.83 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Description

The researchers adjusted for several factors, including BMI and HbA1c at baseline, Social Vulnerability Index, sex, age, race and ethnicity and insulin use history

doi: 10.1210/clinem/dgab927 24 ZuckerIZloofYBardugoATsurAMLutskiMCohenYet al

Obesidade exige tratamento multidisciplinar Considerada uma doena crnica, a obesidade aumenta a cada dia: estima-se que cerca de 30% da populao adulta estar acima do peso em 2030